\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ palpable\\ thyroid\\ nodules\\.\\ \\ currently\\ taking\\ thyroid\\ replacement\\ therapy\\ under\\ endocrinology\\ care\\ and\\ is\\ euthyroid\\.\ \(0\)\
\-\ closely\\ monitor\\ thyroid\\ function\\.\\ \\ \\ patients\\ are\\ at\\ risk\\ for\\ developing\\ thyroid\\ lymphoma\\.\\ \\ monitor\\ for\\ other\\ autoimmune\\ disorders\\.\\ screen\\ family\\ members\\.\ \(0\)\
\-\ enlarged\\,\\ hypoechoic\\,\\ and\\ heterogenous\\ grainy\\ with\\ multiple\\ tiny\\ 1\\ \\-\\ 6\\ mm\\ nodules\\.\\ \\ late\\ stage\\ may\\ appear\\ fibrotic\\.\\ \\ the\\ thryoid\\ gland\\ most\\ often\\ has\\ normal\\ sonographic\\ blood\\ flow\\.\ \(0\)\
\-\ hashimoto\\'s\\ thyroiditis\ \(0\)\
\-\ graves\\ disease\\ if\\ subclinical\\.\\ \\ thyroid\\ blood\\ flow\\ may\\ be\\ helpful\\ in\\ differentiating\\ disease\\ spectrum\\.\\ \\ \ \(0\)\
\-\ riedels\\ thryoiditis\\ if\\ fibrosis\\ is\\ predominant\\ pattern\\ but\\ hashimotos\\ is\\ confined\\ to\\ gland\\.\ \(0\)\
\-\ primary\\ thyroid\\ lymphoma\\.\\ closely\\ associated\\ with\\ hashimoto\\'s\\ thyroiditis\ \(0\)\
\-\ dequervain\\ thyroiditis\\ is\\ subacute\\ viral\\ induced\\ thryoiditis\\ with\\ sonographically\\ edematous\\ and\\ hypoechoic\\ thyroid\\ gland\\.\ \(0\)\
\-\ mom\\ with\\ history\\ of\\ autoimmune\\ thyroiditis\\.\\ \\ patient\\ complains\\ of\\ fatigue\\.\ \(0\)\
\-\ the\\ young\\ male\\'s\\ mother\\ has\\ history\\ of\\ thyroiditis\\.\\ \\ his\\ enlarged\\ gland\\ and\\ clinical\\ hypothyroidism\\ increased\\ the\\ probabilty\\ of\\ his\\ autoimmune\\ thyroiditis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ thyroiditis\\:\\ 0\\.19219754355290541\ \(0\)\
\-\ thyroid\\:\\ 0\\.14592968520519628\ \(0\)\
\-\ thryoiditis\\:\\ 0\\.10494664790436307\ \(0\)\
\-\ autoimmune\\:\\ 0\\.0972896891782147\ \(0\)\
\-\ gland\\:\\ 0\\.08665163550934926\ \(0\)\
\-\ hashimoto\\:\\ 0\\.07352929874227665\ \(0\)\
\-\ closely\\:\\ 0\\.061332818783772045\ \(0\)\
\-\ monitor\\:\\ 0\\.05790803220696512\ \(0\)\
\-\ grainy\\:\\ 0\\.05247332395218154\ \(0\)\
\-\ \\-graves\\:\\ 0\\.05247332395218154\ \(0\)\
\-\ \\-riedels\\:\\ 0\\.05247332395218154\ \(0\)\
\-\ hashimotos\\:\\ 0\\.05247332395218154\ \(0\)\
\-\ \\-dequervain\\:\\ 0\\.05247332395218154\ \(0\)\
\-\ probabilty\\:\\ 0\\.05247332395218154\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.046375446406409206\ \(0\)\
\-\ euthyroid\\:\\ 0\\.04593396509106183\ \(0\)\
\-\ thryoid\\:\\ 0\\.04593396509106183\ \(0\)\
\-\ nodules\\:\\ 0\\.04217284363574704\ \(0\)\
\-\ subclinical\\:\\ 0\\.04180808901630025\ \(0\)\
\-\ \\-primary\\:\\ 0\\.038767460303407456\ \(0\)\
\-\ endocrinology\\:\\ 0\\.03635397751704933\ \(0\)\
\-\ fibrotic\\:\\ 0\\.03635397751704933\ \(0\)\
\-\ members\\:\\ 0\\.03596981965313522\ \(0\)\
\-\ sonographically\\:\\ 0\\.03596981965313522\ \(0\)\
\-\ enlarged\\:\\ 0\\.034709774647428644\ \(0\)\
\-\ differentiating\\:\\ 0\\.034641584228645876\ \(0\)\
\-\ mom\\:\\ 0\\.034351166584780206\ \(0\)\
\-\ \\'s\\:\\ 0\\.03364368961369723\ \(0\)\
\-\ flow\\:\\ 0\\.03361968901022043\ \(0\)\
\-\ predominant\\:\\ 0\\.032855247368822435\ \(0\)\
\-\ tiny\\:\\ 0\\.03184394357837364\ \(0\)\
\-\ edematous\\:\\ 0\\.031142854080418978\ \(0\)\
\-\ confined\\:\\ 0\\.030666409391886022\ \(0\)\
\-\ induced\\:\\ 0\\.030515708153884293\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.029814618655929635\ \(0\)\
\-\ screen\\:\\ 0\\.029555778703907378\ \(0\)\
\-\ spectrum\\:\\ 0\\.02943046079201552\ \(0\)\
\-\ his\\:\\ 0\\.029320107471987284\ \(0\)\
\-\ lymphoma\\:\\ 0\\.029073793266541494\ \(0\)\
\-\ blood\\:\\ 0\\.027766798482253562\ \(0\)\
\-\ if\\:\\ 0\\.027604088497388515\ \(0\)\
\-\ fatigue\\:\\ 0\\.027184661797125826\ \(0\)\
\-\ taking\\:\\ 0\\.0270169780056574\ \(0\)\
\-\ developing\\:\\ 0\\.02661733929829056\ \(0\)\
\-\ late\\:\\ 0\\.02646470578273498\ \(0\)\
\-\ helpful\\:\\ 0\\.026315888507702733\ \(0\)\
\-\ heterogenous\\:\\ 0\\.026099414435257047\ \(0\)\
\-\ subacute\\:\\ 0\\.026099414435257047\ \(0\)\
\-\ viral\\:\\ 0\\.025622969746724098\ \(0\)\
\-\ replacement\\:\\ 0\\.024828140028720986\ \(0\)\
\-\ sonographic\\:\\ 0\\.024658866604193995\ \(0\)\
\-\ disorders\\:\\ 0\\.02433411074556046\ \(0\)\
\-\ complains\\:\\ 0\\.023638877008975635\ \(0\)\
\-\ mother\\:\\ 0\\.023231330584705036\ \(0\)\
\-\ fibrosis\\:\\ 0\\.02264811386827525\ \(0\)\
\-\ may\\:\\ 0\\.0223134329630729\ \(0\)\
\-\ under\\:\\ 0\\.022226869398702588\ \(0\)\
\-\ young\\:\\ 0\\.022153382280712713\ \(0\)\
\-\ stage\\:\\ 0\\.02169663350552587\ \(0\)\
\-\ function\\:\\ 0\\.021562866506406476\ \(0\)\
\-\ family\\:\\ 0\\.02084709788645661\ \(0\)\
\-\ appear\\:\\ 0\\.020817847798346913\ \(0\)\
\-\ currently\\:\\ 0\\.02015579044650034\ \(0\)\
\-\ pattern\\:\\ 0\\.01944310916113856\ \(0\)\
\-\ has\\:\\ 0\\.019103571077312833\ \(0\)\
\-\ mm\\:\\ 0\\.01870354259997027\ \(0\)\
\-\ risk\\:\\ 0\\.018423849091423132\ \(0\)\
\-\ care\\:\\ 0\\.018346292542075905\ \(0\)\
\-\ palpable\\:\\ 0\\.018027506205951133\ \(0\)\
\-\ disease\\:\\ 0\\.016627827871615524\ \(0\)\
\-\ often\\:\\ 0\\.01622900921737888\ \(0\)\
\-\ clinical\\:\\ 0\\.015650653571821452\ \(0\)\
\-\ 6\\:\\ 0\\.015191191436755203\ \(0\)\
\-\ history\\:\\ 0\\.014050173067941468\ \(0\)\
\-\ therapy\\:\\ 0\\.013599052358575076\ \(0\)\
\-\ is\\:\\ 0\\.0133878756758268\ \(0\)\
\-\ patients\\:\\ 0\\.013164134520035868\ \(0\)\
\-\ increased\\:\\ 0\\.012443361796426522\ \(0\)\
\-\ 1\\:\\ 0\\.012103133142617302\ \(0\)\
\-\ associated\\:\\ 0\\.012002753344688701\ \(0\)\
\-\ most\\:\\ 0\\.011743066319809975\ \(0\)\
\-\ other\\:\\ 0\\.011724038980371717\ \(0\)\
\-\ \\-\\:\\ 0\\.010903145587549783\ \(0\)\
\-\ but\\:\\ 0\\.010848233934723438\ \(0\)\
\-\ multiple\\:\\ 0\\.010713130973090885\ \(0\)\
\-\ male\\:\\ 0\\.009197652011234958\ \(0\)\
\-\ for\\:\\ 0\\.008679858912413276\ \(0\)\
\-\ normal\\:\\ 0\\.007973883658327982\ \(0\)\
\-\ be\\:\\ 0\\.00784379001990434\ \(0\)\
\-\ are\\:\\ 0\\.006933773050771438\ \(0\)\
\-\ at\\:\\ 0\\.006891447338283529\ \(0\)\
\-\ no\\:\\ 0\\.0051216913732369165\ \(0\)\
\-\ patient\\:\\ 0\\.005098761493549928\ \(0\)\
\-\ and\\:\\ 0\\.004285928707909963\ \(0\)\
\-\ \\.\\:\\ 0\\.0038035217247156723\ \(0\)\
\-\ \\,\\:\\ 0\\.003222738875205802\ \(0\)\
\-\ with\\:\\ 0\\.0027858137164259457\ \(0\)\
\-\ of\\:\\ 0\\.0027739000189997243\ \(0\)\
\-\ to\\:\\ 0\\.0025420720740653943\ \(0\)\
\-\ in\\:\\ 0\\.0025083168460729457\ \(0\)\
\-\ the\\:\\ 0\\.0024687372268504607\ \(0\)\
